Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Research ArticlePractice

Pharmacologic management of essential tremor

Mark Lees, Loren Regier and Brent Jensen
Canadian Family Physician March 2010; 56 (3) 250-252;
Mark Lees
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loren Regier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: regierl{at}rxfiles.ca
Brent Jensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • CFPlus
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Additional Files
    • View popup
    Table 1.

    Drug treatment options for ET

    CLASS AND ROLEDRUGDOSE (ORAL) IN ETCOST/MO, $COMMENTS
    β-blockers
    • First-line treatment in moderate to severe limb ET; might be helpful for head tremor6

    Propranolol
    • Inderal, generic

    10–40 mg, 3 times daily
    120–160 mg LA daily
    Range: 60–320 mg/d
    10
    40
    • CI: asthma, uncompensated heart failure, low HR (<50 BPM), low BP (< 90 mm Hg)7

    Metoprolol
    • Lopresor, generic

    50–100 mg twice daily
    100 mg SR daily
    15
    • SE: wheezing, headache, dizziness, drowsiness, and insomnia; decreased HR and BP

    • Lower amplitude not frequency of tremors

    • Stronger evidence for propranolol, a nonselective β-blocker

    Anticonvulsants
    • Primidone is a first-line option in moderate to severe limb ET, especially

    Primidone
    • Mysoline, generic

    62.5 mg at bedtime (increase by 62.5 mg every 7 d)10
    • SE: vertigo, ataxia, unstable gait, drowsiness, headache, polyuria, and rash; start with low dose

    • for those who cannot tolerate β-blockers (primidone more effective than phenobarbital)8,9

    125–250 mg 3 times daily
    Range: ≤ 250–1000 mg/d
    10–12
    • Combination propranolol and primidone occasionally useful

    • Others second-line

    Topiramate
    • Topamax, generic

    100–200 mg twice daily
    (Start: 25 mg twice daily to limit SE)
    100–150
    • Effective in trials but high dropout rates and poor tolerance10,11

    • SE: dizziness, unstable gait, drowsiness, decreased weight, paresthesia, confusion, and difficulty with word finding

    Gabapentin
    • Neurontin, generic

    400–600 mg 3 times daily
    (Start: 100–200 mg to limit SE)
    66–115
    • Limited trials; efficacy inconsistent12–14

    • SE: sedation, dizziness, fatigue, drowsiness, and decreased libido; abuse potential15

    Benzodiazepines
    • Intermittent use for stressful situations that make tremor worse

    Clonazepam
    • Rivotril, generic

    0.25–0.5 mg 3 times daily (up to 6 mg/d but increases sedation)16
    • Limited benefit for tremor, but has hypnotic effect and might help decrease anxiety

    Alprazolam
    • Xanax, generic

    0.25–0.5 mg 3 times daily (average 0.75 mg/d)16
    • SE: tolerance, falls, dependence, daytime sedation, and abuse potential

    Other optionsAmantadine, atenolol, botulinum toxin A, clonidine, clozapine, flunarizine, levetiracetam,16 methazolamide, phenobarbital, pregabalin,17 sotalolVariesVariesNone
    • BP—blood pressure, BPM—beats per minute, CI—contraindications, ET—essential tremor, HR—heart rate, LA—long acting, SE—side effects, SR—sustained release.

    • Data from Jensen and Regier4 and Lyons and Pahwa.5

Additional Files

  • Tables
  • CFPlus Additional Material

    This data supplement contains treatment charts for Essential Tremor and Restless Leg Syndrome.

    Files in this Data Supplement:

    • Adobe PDF - Essential_Tremor.pdf
PreviousNext
Back to top

In this issue

Canadian Family Physician: 56 (3)
Canadian Family Physician
Vol. 56, Issue 3
1 Mar 2010
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacologic management of essential tremor
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Pharmacologic management of essential tremor
Mark Lees, Loren Regier, Brent Jensen
Canadian Family Physician Mar 2010, 56 (3) 250-252;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Pharmacologic management of essential tremor
Mark Lees, Loren Regier, Brent Jensen
Canadian Family Physician Mar 2010, 56 (3) 250-252;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Case description
    • Bringing evidence to practice
    • Bringing evidence to practice
    • Footnotes
    • References
  • Figures & Data
  • CFPlus
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Determining if and how older patients can safely stay at home with additional services
  • Managing type 2 diabetes in primary care during COVID-19
  • Effectiveness of dermoscopy in skin cancer diagnosis
Show more Practice

RxFiles

  • How to help patients navigate genitourinary syndrome of menopause
  • Perles cliniques sur la prise en charge des migraines
  • Clinical pearls for management of migraines
Show more RxFiles

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire